Prosecution Insights
Last updated: July 17, 2026
Application No. 17/255,677

NEEDLELESS INJECTION SYSTEM

Final Rejection §112
Filed
Dec 23, 2020
Priority
Jun 26, 2018 — FR 18 55736 +1 more
Examiner
VARGAS, ANNA ELIZABETH
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
L'Oréal
OA Round
4 (Final)
60%
Grant Probability
Moderate
5-6
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 60% of resolved cases
60%
Career Allowance Rate
77 granted / 129 resolved
-10.3% vs TC avg
Strong +54% interview lift
Without
With
+54.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
26 currently pending
Career history
164
Total Applications
across all art units

Statute-Specific Performance

§103
91.3%
+51.3% vs TC avg
§102
2.2%
-37.8% vs TC avg
§112
6.1%
-33.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 129 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment This office action is responsive to the amendment filed on 23 March 2026. As directed by the amendment: claims 1, 3, and 13 have been amended. Thus claims 1-16 are presently pending in this application. Applicant’s amendments to the Claims have overcome each objection and 35 U.S.C. 112(b) rejection previously set forth in the Non-Final Office Action mailed 23 December 2025, however, the amendments require new objections and 35 U.S.C. 112(b) rejections as outlined below. Response to Arguments Applicant’s arguments, see REMARKS, filed 23 March 2026, with respect to amended claim 1 have been fully considered and are persuasive. The claim rejections have been withdrawn. Claim Objections Claim 1 is objected to because of the following informalities: Claim 1, lines 12-13 recites “enabling the gas to be directed towards the surface such as the surface capture cold generated”. The grammar is confusing, this should instead recite “enabling the gas to be directed towards the surface such that the surface captures the cold generated”. Appropriate correction is required. Claim Interpretation The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked. As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph: (A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function; (B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and (C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function. Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function. Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function. Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. This application includes one or more claim limitations that do not use the word “means,” but are nonetheless being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, because the claim limitation(s) uses a generic placeholder that is coupled with functional language without reciting sufficient structure to perform the recited function and the generic placeholder is not preceded by a structural modifier. Such claim limitation(s) is/are: propelling mechanism in claim 1. Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification as performing the claimed function, and equivalents thereof. If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-16 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites the limitation “propelling the composition into the human keratin materials" in line 9. There is insufficient antecedent basis for this limitation in the claim. Additionally, line 14 recites “transmit it towards human keratin materials” which should recite “the human keratin materials” as this is introduced in line 9. Claim 1 recites “transmit it towards human keratin”. It is unclear what “it” is. For the purpose of examination, this is interpreted as “transmit the cold Claims 2-16 are rejected as being dependent on, and failing to cure the deficiencies of, rejected independent claim 1. Allowable Subject Matter Claims 1-16 would be allowable if rewritten or amended to overcome the rejection(s) of claim 1 under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action. The following is a statement of reasons for the indication of allowable subject matter: The closest art of record is Plan (US 20180214644 A1), Azar (US 20090240230 A1), Keyes (US 2746264 A), and Erez et al. (US 5578014 A). Plan discloses a needleless injection system for injecting a composition, the system comprising and/or designed to receive a reservoir containing a pressurized gas, stored in gaseous and/or liquefied form, the system comprising; a connection and distribution interface comprising a reservoir connector in communication with a plurality of conveying ducts. Plan fails to disclose a propelling mechanism, one or more first ducts of the conveying ducts being connected to the propelling mechanism, the first ducts enabling the gas to be directed towards the propelling mechanism for propelling the composition into the human keratin materials using the gas pressure; a surface, one or more second ducts of the conveying ducts being connected to the surface, the second ducts, enabling the gas to be directed towards the surface such as the surface capture cold generated by an expansion of the pressurized gas and to transmit it towards human keratin materials in order to cool the human keratin materials. Azar teaches a needle free injection system using gas pressure to inject a liquid, however, a modification of Plan with Azar would not result in a propelling mechanism being connected to conveying ducts as claimed. Keyes teaches a system for cooling skin using gas decompressing and having conveying ducts; however, Keyes is silent to injecting a liquid. Erez et al. teaches a system that injects a liquid and cools skin, however, the injection and the cooling do not use gas decompression and use two separate mechanisms. As allowable subject matter has been indicated, applicant's reply must either comply with all formal requirements or specifically traverse each requirement not complied with. See 37 CFR 1.111(b) and MPEP § 707.07(a). Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Anna Vargas whose telephone number is (571)270-3873. The examiner can normally be reached Mon-Fri 4:00 PM-9:00 PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Bhisma Mehta can be reached at 571-272-3383. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /A.E.V./Examiner, Art Unit 3783 /COURTNEY FREDRICKSON/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Show 2 earlier events
Mar 15, 2024
Non-Final Rejection mailed — §112
Jun 13, 2024
Response Filed
Sep 10, 2024
Final Rejection mailed — §112
Jan 06, 2025
Request for Continued Examination
Jan 07, 2025
Response after Non-Final Action
Dec 23, 2025
Non-Final Rejection mailed — §112
Mar 23, 2026
Response Filed
Jun 10, 2026
Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12667662
SMART MEDICATION DELIVERY DEVICES FOR PROVIDING USERS WITH DELIVERY INFOMATICS AND METHODS OF USING SAME
3y 1m to grant Granted Jun 30, 2026
Patent 12636486
LOCALISED TRANSDERMAL IONTOPHORETIC DRUG DELIVERY SYSTEM
5y 6m to grant Granted May 26, 2026
Patent 12629486
DEVICES AND METHODS TO CREATE A PROTECTIVE GAS CUSHION
5y 6m to grant Granted May 19, 2026
Patent 12569628
DELIVERY OF MEDICINAL GAS IN A LIQUID MEDIUM
2y 11m to grant Granted Mar 10, 2026
Patent 12535865
3D Printable Light Shade for Medical Devices
4y 0m to grant Granted Jan 27, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
60%
Grant Probability
99%
With Interview (+54.1%)
3y 3m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 129 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month